Simultaneous determination of epothilone D and its hydrolytic metabolite in human plasma by high performance liquid chromatography-tandem mass spectrometry for pharmacokinetic studies

被引:3
作者
Zhang, Chunling [1 ,2 ]
Zhao, Lanjiao [1 ,2 ]
Qi, Wenyuan [1 ]
Meng, Zhiyun [1 ]
Sun, Guoxiang [2 ]
Dou, Guifang [1 ]
机构
[1] Beijing Inst Transfus Med, Lab Drug Metab & Pharmacokinet, Beijing 100850, Peoples R China
[2] Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2009年 / 877卷 / 29期
关键词
Epothilone D; Hydrolytic metabolite; HPLC-MS/MS; Pharmacokinetics; DESOXYEPOTHILONE-B; NUDE-MICE;
D O I
10.1016/j.jchromb.2009.08.052
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive, simple and rapid high performance liquid chromatographic-tandem mass spectrometric (HPLC-MS/MS) method was developed for Simultaneous quantitation of epothilone D and its major metabolite, the hydrolytic metabolite, epothilone C as internal standard in human plasma. Plasma samples were precipitated with acetonitrile, the analysis used a Venusil ASB C-18 analytical column. A tandem mass spectrometer equipped with electrospray ionization source was used as detector and operated in the positive-ion mode. Selected reaction monitoring(SRM) using the precursor to product ion pairs of m/z 492.3 -> 304.1 (epothilone D), m/z 510.3 -> 492.3 (metabolite), m/z 478.3 -> 290.1 (internal standard) was used for quantification. The analytical method was validated in terms of specificity, precision, accuracy, extraction recovery, stability, matrix effect and dilution effect. The linear calibration curves of epothilone D and metabolite were obtained over the concentration range of 0.2-1000 ng/ml and 5.0-1000 ng/ml, respectively. Lower limits of quantification (LLOQ) of epothilone D and metabolite were 0.2 ng/ml and 5.0 ng/ml, respectively. Due to its high sensitivity, specificity and simplicity. the method could be used for pharmacokinetic studies of both epothilone D and its hydrolytic metabolite. Crown Copyright (C) 2009 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3748 / 3752
页数:5
相关论文
共 13 条
  • [1] Recent developments in the chemical biology of epothilones
    Altmann, KH
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (13) : 1595 - 1613
  • [2] Epothilones and related structures - a new class of microtubule inhibitors with potent in vivo antitumor activity
    Altmann, KH
    Wartmann, M
    O'Reilly, T
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2000, 1470 (03): : M79 - M91
  • [3] [Anonymous], [No title captured]
  • [4] Key elements of bioanalytical method validation for small molecules
    Bansal, Surendra
    DeStefano, Anthony
    [J]. AAPS JOURNAL, 2007, 9 (01) : E109 - E114
  • [5] Blum W, 2001, RAPID COMMUN MASS SP, V15, P41, DOI 10.1002/1097-0231(20010115)15:1<41::AID-RCM190>3.0.CO
  • [6] 2-W
  • [7] BOLLAG DM, 1995, CANCER RES, V55, P2325
  • [8] Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel
    Chou, TC
    Zhang, XG
    Harris, CR
    Kuduk, SD
    Balog, A
    Savin, KA
    Bertino, JR
    Danishefsky, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15798 - 15802
  • [9] Desoxyepothilone B:: An efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B
    Chou, TC
    Zhang, XG
    Balog, A
    Su, DS
    Meng, DF
    Savin, K
    Bertino, JR
    Danishefsky, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) : 9642 - 9647
  • [10] Preclinical pharmacology of epothilone D, a novel tubulin-stabilizing antitumor agent
    Wang, H
    Wang, Z
    Wang, SY
    Li, M
    Nan, L
    Rhie, JK
    Covey, JM
    Zhang, RW
    Hill, DL
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (03) : 255 - 260